PIPA Pitches FIOS AI Platform to Help Food Makers Meet GLP-1 Demand
PIPA, an AI systems company for food intelligence, says its Food Innovation Operating System, FIOS, can help food manufacturers rework products for the growing number of households with GLP-1 users. The platform links AI-assisted formulation with physics-based digital twins of manufacturing processes, according to the company.
- PIPA says its FIOS platform combines agentic AI formulation with physics-based digital twins of manufacturing processes.
- According to PwC, 21% of U.S. households included a GLP-1 user in May 2026, up from 9% in January 2025.
- PIPA claims up to 40% performance gains when formulation optimization connects with process parameters.
- Circana finds 65% of GLP-1 users seek more protein.
- PIPA says FIOS can be tried free at pipacorp.com.
GLP-1 adoption changes the brief for food makers
PIPA frames the news around a formulation problem: the food industry must deliver more nutrition in smaller portions without sacrificing taste, texture or affordability. The company cites several figures from outside research to describe the shift.
- According to PwC, 21% of U.S. households included a current GLP-1 user in May 2026, up from 9% in January 2025.
- Circana finds that 65% of GLP-1 users seek more protein.
- BCG reports that 70% of users see eating or fitness habits change across their households.
PIPA argues that demand extends beyond people taking the medication, which in its view makes mainstream reformulation critical.
Why reformulation is hard
Adding protein or fiber affects structure, taste, processing, stability and cost, according to PIPA. Improving one target can undermine another, which makes trial-and-error development expensive.
FIOS, which stands for Food Innovation Operating System, is the company's answer to that problem. It connects AI-assisted formulation exploration with physics-based digital twins of the manufacturing process.
How FIOS works
PIPA says agentic workflows in FIOS screen ingredient combinations against nutritional, functional and commercial targets. Process models then anticipate outcomes on the production line before costly physical trials take place.
The company claims users see up to 40% performance gains when formulation optimization connects with downstream process parameters. The figure is PIPA's own claim, and the announcement does not explain how performance is measured.
Eric Hamborg, CCO of PIPA, said: "GLP-1 is changing the brief for everyday foods." He added that manufacturers need to deliver more nutritional value per bite while preserving taste and price, and that FIOS lets teams work through those trade-offs at the formulation stage, "where they are cheap to fix."
What it means for the food industry
For manufacturers, the pitch is that trade-offs between nutrition, taste, processing and cost can be tested digitally before production trials begin. PIPA says this applies to everyday foods, not only products aimed at medication users.
PIPA also offers LEAP, a platform for scientific discovery and ingredient innovation. The company says FIOS can be tried free at pipacorp.com. The announcement gives no pricing, customer names or independent validation of the performance claim.
